Scarica l'app Stockscreener
3.21
0.31%
0.010
Dopo l'orario di chiusura:
3.21
Precedente Chiudi:
$3.20
Aprire:
$3.21
Volume 24 ore:
1,799
Relative Volume:
0.19
Capitalizzazione di mercato:
$58.71M
Reddito:
-
Utile/perdita netta:
$-9.64M
Rapporto P/E:
-6.0842
EPS:
-0.5276
Flusso di cassa netto:
$-6.76M
1 W Prestazione:
-2.73%
1M Prestazione:
+3.88%
6M Prestazione:
-17.24%
1 anno Prestazione:
-45.13%
Intervallo 1D:
$3.21
$3.36
Intervallo di 1 settimana:
$3.05
$3.47
Portata 52W:
$2.56
$6.20
Genenta Science Spa Adr Stock (GNTA) Company Profile
Nome
Genenta Science Spa Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta GNTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
3.21 | 60.50M | 0 | -9.64M | -6.76M | -0.5276 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-06-29 | Ripresa | ROTH MKM | Buy |
| 2022-07-25 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-13 | Iniziato | Maxim Group | Buy |
Genenta Science Spa Adr Borsa (GNTA) Ultime notizie
Genenta Science Reports Reduced Losses and Strengthened Balance Sheet for H1 2025 - TipRanks
Leadership Change at Genenta Science SpA: Dr. Galimi Appointed Acting CMO - The Globe and Mail
Genenta Science S.p.A. Unsponsored ADR (NASDAQ:GNTA) Short Interest Update - MarketBeat
Can Genenta Science S.p.A. (Common Stock) (K5F) stock hold up in economic slowdownGap Down & Community Driven Trade Alerts - newser.com
Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail
Genenta Science (NASDAQ:GNTA) Stock Price Down 1.9%Here's What Happened - MarketBeat
Analyzing Genenta Science S.p.A. Depositary Receipt with multi timeframe chartsWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Genenta Science S.p.A. Announces Shareholders’ Meeting for Strategic Amendments - TipRanks
Genenta Science (NASDAQ:GNTA) Trading 7.4% HigherHere's Why - MarketBeat
Real time alert setup for Trinity Capital Inc. performanceJuly 2025 Drop Watch & Capital Protection Trading Alerts - Newser
Using data filters to optimize entry into Genenta Science S.p.A. Depositary ReceiptJuly 2025 News Drivers & High Accuracy Investment Signals - Newser
Assembly Biosciences Inc. stock trend outlook and recovery pathGDP Growth & Safe Capital Growth Tips - Newser
Genenta Science S.p.A. to Terminate Dedicated Suite Agreement with AGC Biologics - MSN
Genenta Science (NASDAQ:GNTA) Trading 7.4% Higher – Time to Buy? - Defense World
Will Genenta Science S.p.A. Depositary Receipt stock go up soonJuly 2025 News Drivers & Entry and Exit Point Strategies - Newser
How moving averages guide Genenta Science S.p.A. Depositary Receipt tradingTrade Signal Summary & Safe Capital Investment Plans - Newser
Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX), Iovance Biotherapeutics (IOVA) and NextCure (NXTC) - The Globe and Mail
Applying sector rotation models to Altice USA Inc.Free Risk Managed Intraday Trade Alerts - Newser
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Gilead Sciences (GILD) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail
Genenta Science stock maintains Buy rating as Temferon shows promise in GBM - Investing.com
Genenta secures $21.9 million for cancer drug trial - Investing.com
Oncology Breakthroughs: How Cancer Research Is Advancing in 202527.02.25News - Ariva
Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance
Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
10 Best Italian Stocks To Buy Now - Yahoo Finance
Trading Halts Explained - MarketBeat
Stock Market Alerts - MarketBeat
Genenta Science Spa Adr Azioni (GNTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):